Ortiz-Olvera NX, Castellanos-Pallares G, Gómez-Jiménez LM, Cabrera-Muñoz ML, Méndez-Navarro J, Morán-Villota S, Dehesa-Violante M

Language: English
References: 19
Page: 321-326
PDF size: 47.43 Kb.

ABSTRACT

Background. It has been suggested that liver cirrhosis (LC), regardless of etiology, may be associated with anatomical cardiac alterations. Objective. To describe the frequency and type of macroscopical anatomic cardiac abnormalities present in alcoholic and non-alcoholic cirrhotic patients in an autopsy series. Material and methods. The autopsy records performed at our institution during a 12-year period (1990-2002) were reviewed. All cases with final diagnosis of LC were included, their demographic characteristics as well as cirrhosis etiology and macroscopic anatomical cardiac abnormalities (MACA) analyzed. Patients with any known history of heart disease prior to diagnosis of cirrhosis were excluded. Results. A total of 1,176 autopsies were performed, of which 135 cases (11.5%) were patients with LC. Two patients with cardiac cirrhosis were excluded. Chronic alcohol abuse (29%) and chronic hepatitis due to hepatitis C virus (HCV) infection (20%) were the most common causes of cirrhosis. The etiology was not identified in 35% of the cases, even after exhaustive clinical, serological and/or radiological assessment. In the postmortem analysis, 43% of the cases were informed to have MACA (47% in the group of patients with alcoholic cirrhosis and 41% in other types of cirrhosis); this rate increased to 62% in patients with ascites. The most frequent alterations were cardiomegaly and left ventricular hypertrophy (LVH). Conclusion. The results confirm the high frequency of cardiac abnormalities in patients with cirrhosis, regardless of cirrhosis etiology.

REFERENCES

1. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451-9.

2. Ruiz-del-Árbol L, Monescillo A, Arocena C, Valer P, Ginés P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42: 439-47.

3. Bethke BA, Schubert GE. Primary hepatic cancer and liver cirrhosis. Autopsy study covering fifty years. Hepatogastroenterology 1984; 31: 211-4.

4. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec´s cirrhosis. J Clin Invest 1953; 32: 1025-33.

5. Møller S, Henriksen JH. The systemic circulation in cirrhosis. In: Ginés P, Arroyo V, Podes J, Schrier RW (eds.). Ascites and renal dysfunction in liver disease. 2nd. Ed. Malden: Blackwell Science; 2005, p. 139-55.

6. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009; 3: 294-304.

7. Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010; 56: 539-49.

8. Møller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010; 53: 179-90.

9. Al-Hamoudi WK. Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi J Gastroenterol 2010; 16: 145-53.

10. Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred and eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med 1958; 102: 405-13.

11. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978; 31: 395-414.

12. Rutherford AE, Pratt DS. Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 2006; 22: 209-14.

13. Pérez-Tamayo R. Las causas de muerte en México. En: Pérez T (ed.). Introducción a la Patología. 1a. Ed. México: Edit Melo, S.A.; 1976, p. 389-97.

14. Hoefs JC. Characteristics of ascites. In: Arroyo V, Ginés P, Podes J, Schrier RW (eds). Ascites and renal dysfunction in liver disease. 1a. Ed. Malden: Blackwell Science; 1999, p. 14-35.

15. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3: 30-3.

16. Hall EM, Olsen AY, Davis FE. Portal Cirrhosis: Clinical and pathological review of 782 cases from 16,600 necropsies. Am J Pathol 1953; 29: 993-1027.

17. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989; 151: 530-5.

18. Spatt SD, Rosenblatt P. The incidence of hypertension in portal cirrhosis: A study of 80 necropsied cases of portal cirrhosis. Ann Intern Med 1949; 31: 479-83.

19. Torregrosa M, Aguadé S, Dos L, Segura R, González A, Evangelista A, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005; 42: 68-74.